Insider Trading: Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

88.59USD
21 May 2013
Price Change (% chg)

$0.58 (+0.66%)
Prev Close
$88.01
Open
$88.00
Day's High
$88.64
Day's Low
$87.80
Volume
2,935,961
Avg. Vol
2,605,912
52-wk High
$88.64
52-wk Low
$61.71

Search Stocks
ULLMANN MICHAEL H Options Exercised: 1,352
Trade Date: Thursday, 24 Jan 2013 Price: 52.20
Title: General Counsel Shares Held: 47,109
Type Traded: Direct Net Change in Shares This Filing: 563
» More Insider Trading

Institutional Holders

% Shares Owned: 68.77%
# of Holders: 2,308
Total Shares Held: 1,931,644,204
3 Mo. Net Change: 35,180,773
# New Positions: 88
# Closed Positions: 78
# Increased Positions: 918
# Reduced Positions: 917
# Net Buyers: 1

Officers & Directors

Name Age Since Current Position

Alex Gorsky

 52 2012 Chairman of the Board, Chief Executive Officer

Dominic Caruso

 55 2007 Chief Financial Officer, Vice President - Finance

Sandra Peterson

 54 2012 Group Worldwide Chairman

Paulus Stoffels

 51 2012 Chief Scientific Officer, Worldwide Chairman - Pharmaceuticals Group

Michael Ullmann

 54 2012 Vice President, General Counsel

Peter Fasolo

 50 2010 Vice President - Global Human Resources

Anne Mulcahy

 60 2012 Lead Independent Director

Mary Coleman

 69 2003 Independent Director

James Cullen

 70 Presiding Independent Director

Ian Davis

 62 2010 Independent Director

Michael Johns

 71 2005 Independent Director

Susan Lindquist

 63 2004 Independent Director

Leo Mullin

 70 1999 Independent Director

William Perez

 65 2007 Independent Director

Charles Prince

 63 2006 Independent Director

A. Eugene Washington

 62 2012 Independent Director

Ronald Williams

 63 2011 Independent Director

Louise Mehrotra

 Vice President, Investor Relations
Search Stocks